Translational Challenges
Global Health
Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases.
Infectious diseases disregard national borders. They are some of the biggest threats facing human health.
Within the umbrella of global health, we have focused on 3 Translational Challenges: antimicrobial resistance, emerging viral threats, and neglected tropical diseases.
We collaborate with experts in this space and use our expertise in translation to help remove barriers and progress promising science.
Translational Challenges within Global Health
Antimicrobial Resistance (AMR)
Partnering to fight drug-resistant infections.
Neglected Tropical Diseases
Supporting the elimination and control of tropical diseases.
Emerging Viral Threats (EVTs)
Tackling established viruses and potential epidemics.
What do we want to achieve?
Focusing our efforts where patient need is greatest and listening to those with lived experiences, we aim to:
- improve understanding of diseases
- connect experts across global health research
- support sustainable capacity growth
- contribute to making medicines and diagnostics affordable and accessible
- unblock barriers that keep solutions from reaching patients
How you can work with us
Partnerships
We pursue collaborations that:
- Focus on urgent local needs in low- and middle-income countries
- Aim to create a more equitable and sustainable global research ecosystem
Funding
We invest in projects that:
- Co-create new research infrastructure
- Support capacity growth where it’s most needed
- Remove obstacles in the scientific discovery pathway
- Create more opportunities for funding
Scientific support
Our team can help you:
- Translate new therapeutics
- Develop diagnostics and biomarkers
- Discover and humanise antibodies
- Protect your intellectual property
Partnerships and initiatives
Grand Challenges African Drug Discovery Accelerator programme
In collaboration with the Bill & Melinda Gates Foundation we are investing £6 million in the Grand Challenges African Drug Discovery Accelerator (GC ADDA) programme.
PACE
A £30 million initiative with Innovate UK and Medicines Discovery Catapult, driving new developments to tackle antimicrobial resistance.
iiCON and the Liverpool School of Tropical Medicine
We are partnering with the Liverpool School of Tropical Medicine (LSTM) to launch a new £2.7 million Translational Development Fund.
The Francis Crick Institute and the Crick Africa Network
We have partnered with the Crick Africa Network (CAN), to provide £7.5 million towards community science programmes.
Related stories
-
News releasesNew £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya -
News releasesLifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
Read more: LifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership -
News releasesReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
Read more: ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
Who to contact
-
Mike Strange
Read bio: Mike Strange
-
Julie Brady
Read bio: Julie Brady
-
Magalie Rocheville
Read bio: Magalie Rocheville
See our other Translational Challenges
Motor Neuron Disease
Our vision is a world where motor neuron disease is preventable and treatable.
Chronic Respiratory Infection
Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis.
Rare Disease
Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster.
Childhood Cancer
Our vision is to drive life-changing innovations for children with cancer.
Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.